|
1
|
Global Burden of Disease Study 2013
Collaborators: Global, regional, and national incidence,
prevalence, and years lived with disability for 301 acute and
chronic diseases and injuries in 188 countries, 1990–2013: A
systematic analysis for the Global Burden of Disease Study 2013.
Lancet. 386:743–800. 2015. View Article : Google Scholar
|
|
2
|
GBD 2013 Mortality and Causes of Death
Collaborators: Global, regional, and national age-sex specific
all-cause and cause-specific mortality for 240 causes of death,
1990–2013: a systematic analysis for the Global Burden of Disease
Study 2013. Lancet. 385:117–171. 2015. View Article : Google Scholar
|
|
3
|
Elias JA, Lee CG, Zheng T, Ma B, Homer RJ
and Zhu Z: New insights into the pathogenesis of asthma. J Clin
Invest. 111:291–297. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Robinson DS, Hamid Q, Ying S, Tsicopoulos
A, Barkans J, Bentley AM, Corrigan C, Durham SR and Kay AB:
Predominant TH2-like bronchoalveolar T-lymphocyte population in
atopic asthma. N Engl J Med. 326:298–304. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Okayama Y, Ra C and Saito H: Role of mast
cells in airway remodeling. Curr Opin Immunol. 19:687–693. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Holgate ST: Epithelium dysfunction in
asthma. J Allergy Clin Immunol. 120:1233–1244; quiz 1245–1246.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McFadden ER Jr: Acute severe asthma. Am J
Respir Crit Care Med. 168:740–759. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sinigaglia F and D'Ambrosio D: Regulation
of helper T cell differentiation and recruitment in airway
inflammation. Am J Respir Crit Care Med. 162:S157–S160. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Broide DH: Immunologic and inflammatory
mechanisms that drive asthma progression to remodeling. J Allergy
Clin Immunol. 121:560–570; quiz 571–572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cho JY, Miller M, Baek KJ, Han JW, Nayar
J, Lee SY, McElwain K, McElwain S, Friedman S and Broide DH:
Inhibition of airway remodeling in IL-5-deficient mice. J Clin
Invest. 113:551–560. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pascual RM and Peters SP: Airway
remodeling contributes to the progressive loss of lung function in
asthma: An overview. J Allergy Clin Immunol. 116:477–486; quiz 487.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Flood-Page P, Menzies-Gow A, Phipps S,
Ying S, Wangoo A, Ludwig MS, Barnes N, Robinson D and Kay AB:
Anti-IL-5 treatment reduces deposition of ECM proteins in the
bronchial subepithelial basement membrane of mild atopic
asthmatics. J Clin Invest. 112:1029–1036. PubMed/NCBI
|
|
13
|
Panettieri RA Jr: Cellular and molecular
mechanisms regulating airway smooth muscle proliferation and cell
adhesion molecule expression. Am J Respir Crit Care Med.
158:S133–S140. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jeffery PK: Remodeling in asthma and
chronic obstructive lung disease. Am J Respir Crit Care Med.
164:S28–S38. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wenzel S: Severe asthma in adults. Am J
Respir Crit Care Med. 172:149–160. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tagaya E and Tamaoki J: Mechanisms of
airway remodeling in asthma. Allergol Int. 56:331–340. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mauad T, Bel EH and Sterk PJ: Asthma
therapy and airway remodeling. J Allergy Clin Immunol.
120:997–1009; quiz 1010–1011. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vanacker NJ, Palmans E, Kips JC and
Pauwels RA: Fluticasone inhibits but does not reverse
allergen-induced structural airway changes. Am J Respir Crit Care
Med. 163:674–679. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu JJ, Huang RW, Lin DJ, Wu XY, Peng J,
Pan XL, Song YQ, Lin Q, Hou M, Wang DN, et al: Oridonin-induced
apoptosis in leukemia K562 cells and its mechanism. Neoplasma.
52:225–230. 2005.PubMed/NCBI
|
|
20
|
Chen S, Gao J, Halicka HD, Huang X,
Traganos F and Darzynkiewicz Z: The cytostatic and cytotoxic
effects of oridonin (Rubescenin), a diterpenoid from Rabdosia
rubescens, on tumor cells of different lineage. Int J Oncol.
26:579–588. 2005.PubMed/NCBI
|
|
21
|
Ren KK, Wang HZ, Xie LP, Chen DW, Liu X,
Sun J, Nie YC and Zhang RQ: The effects of oridonin on cell growth,
cell cycle, cell migration and differentiation in melanoma cells. J
Ethnopharmacol. 103:176–180. 2006. View Article : Google Scholar
|
|
22
|
Liu JJ, Wu XY, Peng J, Pan XL and Lu HL:
Antiproliferation effects of oridonin on HL-60 cells. Ann Hematol.
83:691–695. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu Y, Xue Y, Wang Y, Feng D, Lin S and Xu
L: Multiple-modulation effects of Oridonin on the production of
proinflammatory cytokines and neurotrophic factors in LPS-activated
microglia. Int Immunopharmacol. 9:360–365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu J, Yang F, Zhang Y and Li J: Studies
on the cell-immunosuppressive mechanism of Oridonin from Isodon
serra. Int Immunopharmacol. 7:945–954. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu AP, Du JM, Li JY and Liu JW: Oridonin
promotes CD4+/CD25+ Treg differentiation, modulates Th1/Th2 balance
and induces HO-1 in rat splenic lymphocytes. Inflamm Res.
57:163–170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Committee for the Update of the Guide for
the Care and Use of Laboratory Animals: Guide for the Care and Use
of Laboratory Animals. 8th edition. National Academies Press;
Washington, D.C: 2011
|
|
27
|
Xue H, Guo H, Li YC and Hao ZM: Heme
oxygenase-1 induction by hemin protects liver cells from
ischemia/reperfusion injury in cirrhotic rats. World J
Gastroenterol. 13:5384–5390. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Myou S, Leff AR, Myo S, Boetticher E, Tong
J, Meliton AY, Liu J, Munoz NM and Zhu X: Blockade of inflammation
and airway hyperresponsiveness in immune-sensitized mice by
dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med.
198:1573–1582. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hansbro PM, Kaiko GE and Foster PS:
Cytokine/anti-cytokine therapy-novel treatments for asthma? Br J
Pharmacol. 163:81–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Possa SS, Leick EA, Prado CM, Martins MA
and Tibério IFLC: Eosinophilic inflammation in allergic asthma.
Front Pharmacol. 4:462013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Duan W, Chan JH, Wong CH, Leung BP and
Wong WS: Anti-inflammatory effects of mitogen-activated protein
kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol.
172:7053–7059. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Abbas AK, Murphy KM and Sher A: Functional
diversity of helper T lymphocytes. Nature. 383:787–793. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim CK, Kita H, Callaway Z, Kim HB, Choi
J, Fujisawa T, Shin BM and Koh YY: The roles of a Th2 cytokine and
CC chemokine in children with stable asthma: Potential implication
in eosinophil degranulation. Pediatr Allergy Immunol. 21:e697–e704.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Busse WW and Lemanske RF Jr: Asthma. N
Engl J Med. 344:350–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Herrick CA and Bottomly K: To respond or
not to respond: T cells in allergic asthma. Nat Rev Immunol.
3:405–412. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ikezoe T, Yang Y, Bandobashi K, Saito T,
Takemoto S, Machida H, Togitani K, Koeffler HP and Taguchi H:
Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits
the proliferation of cells from lymphoid malignancies in
association with blockade of the NF-kappaB signal pathways. Mol
Cancer Ther. 4:578–586. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie
J, Zhang FX, Weng XQ, Shen ZX, Chen J, et al: Oridonin, a
diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion
protein and shows potent antitumor activity with low adverse
effects on t(8; 21) leukemia in vitro and in vivo. Blood.
109:3441–3450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wynn TA: IL-13 effector functions. Annu
Rev Immunol. 21:425–456. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lukacs NW: Role of chemokines in the
pathogenesis of asthma. Nat Rev Immunol. 1:108–116. 2001.
View Article : Google Scholar
|
|
40
|
Wills-Karp M: Immunologic basis of
antigen-induced airway hyperresponsiveness. Annu Rev Immunol.
17:255–281. 1999. View Article : Google Scholar : PubMed/NCBI
|
